Drugs use in pregnancy in the Valencia Region and the risk of congenital anomalies

Background Despite the potential risks of drug use during pregnancy, consumption has increased in recent decades. Objective To identify the risk of congenital anomalies (CA) associated with the use of drugs in primary care in pregnant women resident in the Valencia Region. Methods A case-control study, considering a case as a less than one year old live birth in 2009–2010, diagnosed with a CA and resident in the Valencia Region, obtained from the CA population-based registry. Controls were selected from the Metabolic Disease Registry, and the drugs prescribed and dispensed from the Integral Management of Pharmaceutical Services. Crude odds ratio (OR) was calculated with its 95% confidence intervals and adjusted OR was calculated using logistic regression. Results A total of 1.913 cases and 3.826 controls were identified. The most frequently used drug groups were those acting on the musculoskeletal, nervous and respiratory systems, on the blood and blood forming organs, and anti-infection drugs. The most common drugs used were ibuprofen, dexketoprofen, paracetamol, amoxicillin, ferrous sulphate, and a combination of folic acid. A significantly increased risk of CA was identified for drugs acting on the musculoskeletal system (adjusted OR 1.14 [95% confidence interval 1.02–1.28]). A significantly decreased risk was observed for drugs acting on the blood and blood forming organs (adjusted OR 0.87 [95% confidence interval 0.78–0.98]). Conclusions Associations between drugs and CA in pregnant women resident in the Valencia Region have been identified for drugs that act as risk factors of CA, and for drugs that act as protective factors of CA. Antecedentes El consumo de medicamentos durante el embarazo se ha incrementado en las últimas décadas. Objetivo Identificar el riesgo de anomalías congénitas (AC) asociado a la utilización de medicamentos en atención ambulatoria en embarazadas residentes en la Comunitat Valenciana. Métodos Estudio de casos-controles, considerando caso a menores de un año nacidos vivos en 2009-2010 diagnosticados de AC y residentes en la Comunitat Valenciana, obtenidos del registro poblacional de AC. Los controles se seleccionaron del Registro de Metabolopatías y la medicación prescrita y dispensada se obtuvo del módulo Gestión Integral de Prestación Farmacéutica. Se calcularon las odds ratio (OR) y los intervalos de confianza al 95% y las OR ajustadas mediante regresión logística. Resultados Se identificaron 1.913 casos y 3.826 controles. Los grupos de medicamentos más frecuentemente prescritos y dispensados fueron: los que actúan sobre los sistemas musculoesquelético, nervioso, respiratorio, sobre la sangre y órganos hematopoyéticos, y antiinfecciosos. Los medicamentos más habituales fueron: ibuprofeno, dexketoprofeno, paracetamol, amoxicilina, sulfato de hierro y una combinación de ácido fólico. Se identificó un aumento del riesgo de anomalías congénitas significativo para los fármacos de acción sobre el sistema musculoesquelético (OR ajustada de 1,14 [intervalo de confianza al 95% 1,02-1,28]). Se observó una disminución del riesgo significativa en el grupo que actúa sobre la sangre y los órganos hematopoyéticos (OR ajustada de 0,87 [intervalo de confianza al 95% 0,78-0,98]). Conclusiones Se han identificado asociaciones de medicamentos con AC en mujeres embarazadas residentes en la Comunitat Valenciana, tanto para fármacos que actúan como factores de riesgo de AC como para fármacos que actúan como factores protectores de AC

Modifying catalytically the soot morphology and nanostructure in diesel exhaust: Influence of silver De-NOx catalyst (Ag/Al2O3)

The influence of an Ag/Al2O3 HC-SCR catalyst on the morphological and nanostructural aspects of the exhaust particulate matter (PM) generated during the combustion of diesel fuel and a glycol ether–diesel fuel blend was addressed in this research work. In addition, the impact of in-cylinder fuel post injections (FPI) on the particulate formation pathway and on the catalytic de-NOx efficiency was also studied. The tests were carried at low exhaust temperatures in the absence and presence of small amounts of hydrogen (H2). It is concluded that in the absence of H2, the catalyst does not modify the primary particle size (dp0) of the soot aggregates, while the aggregation of the soot particles throughout the catalyst channels is the main governing mechanism. The catalyst influence on the particulate structure was evident when H2 was introduced, with smaller dp0 seen downstream of the catalyst, indicating that despite the short residence time of the PM within the catalyst bed, the soot particles were partially oxidised. The use of late FPI reduces the exhaust PM level and delivers sufficient HC:NOx ratios that improves the catalyst activity up to a maximum of 80% NOx conversion, with no sign of catalyst deactivation when H2 (500 ppm) was injected. Furthermore, it is suggested that along with oxidising part of the particles produced during the main fuel injection phase, late FPI can also produce, to a lesser extent, some additional soot with a less matured structure, resulting on average in less ordered particles being emitted into the exhaust stream. This work shows that in modern diesel engines, a silver catalyst can alter the soot structure in the exhaust in a way that can ease the diesel particulate filter (DPF) regeneration cycles, improve its filtration efficiency and help in effectively reducing the tailpipe NOx emissions. For the catalyst to perform these functions, multiple in-cylinder fuel injection strategies (late FPI) combined with small amounts of hydrogen addition to the exhaust are required

Transformations international experience and research network for sustainable futures

The overarching aim of TransformERS is to inform research, policy and practice for transformations that deliver justice in a changing global context by bringing together and positioning research relevant to societal transformation Such societal transformations are cited as highly necessary to avoid catastrophic climate change and biodiversity loss, and are called for in the IPCC and IPBES frameworks, as well as the European Green Deal However, current research into transformations is highly fragmented Pieces of relevant knowledge are held by policy makers, practitioners, and researchers, from within a range of contexts, disciplines, projects and perspectives, both within and outside of the sustainability research community There is a need to put these separate pieces together to 1 identify what transformation relevant knowledge is held and by whom 2 understand how the different pieces fit together 3 understand what the big picture is what we know about transformations collectively and 4 identify the missing pieces understand what we still need to create knowledge on TransformERS creates a networking infrastructure to meet these 4 needs with objectives to 1 inform transformation policy 2 shape transformations research and practice 3 train transformations researchers from across broad disciplines and topicsinfo:eu-repo/semantics/publishedVersio

Green Production of a High-Value Branched-Chain Diester: Optimization Based on Operating Conditions and Economic and Sustainability Criteria

©. This manuscript version is made available under the CC-BY license http://creativecommons.org/licenses/by/4.0/ This document is the Published version of a Published Work that appeared in final form in [Applied Sciences]. To access the final edited and published work see [https://doi.org/ 10.3390/app13106177]Featured Application: In the last years, consumers’ and administrations’ demand for more sustainable products and processes has been increasing. This work develops a new sustainable way to obtain a branched ester for cosmetic applications (neopentylglycol dilaurate) and demonstrates that this new production route can be economically competitive. Branched-chain esters (BCEs) have found a large number of applications in cosmetics. Among them, neopentyl glycol dilaurate (NPGDL) stands out as an emollient, emulsifier, and skin-conditioning agent. This work presents the synthesis of NPGDL in a solvent-free medium using the two most common immobilized lipases: Novozym® 40086 (Rml) and Novozym® 435 (CalB). Results proved that the former biocatalyst has lower activity and certain temperature deactivation, although conversions ≥ 90% were obtained at 60 °C and 7.5% of catalyst. On the other hand, optimal reaction conditions for Novozym® 435 are 3.75% w/w of the immobilized derivative at 80 °C. Under optimal conditions, the process productivities were 0.105 and 0.169 kg NPGDL/L h, respectively. In order to select the best conditions for NPGDL production, studies on the reuse of the derivative and cost estimation have been performed. Economic study shows that biocatalytic processes can be competitive when lipases are reused for five cycles, yielding biocatalyst productivities of 56 and 122 kg NPGDL/kg biocatalyst using Novozym® 40086 and Novozym® 435, respectively. The final choice will be based on both economic and sustainability criteria. Green metric values using both biocatalysts are similar but the product obtained using Novozym® 40086 is 20% cheaper, making this alternative the best option

Underlying molecular mechanism in the modulation of the ram sperm acrosome reaction by progesterone and 17ß-estradiol

Steroid hormones progesterone (P4) and 17ß-estradiol (E2) not only have important functions in regulation of reproductive processes in mammals but also have direct effects on spermatozoa. There can be induction of the acrosome reaction in ram spermatozoa by P4 and E2 and, in the present study, there was further investigation of mechanisms underlying this effect. In a medium containing agents that increase cAMP, the presence of both P4 and E2 led to changes in the localization of proteins phosphorylated in tyrosine residues evaluated by indirect immunofluorescence. The inclusion of P4 at 1 µM in the media induced an increase in Ca2+i and mobilization in the area of the acrosome (Fluo-4 and Rhod-5 staining, respectively), an increase in ROS (H2DCFDA staining) and a substantial disruption of the acrosome (evaluated using RCA), while E2 did not have these effects. There were no effects on cAMP concentrations or PKA activity with inclusion of these hormones in the media. The inclusion of P4 at 100 pM in the media led to changes in values for sperm kinematic variables which could indicate there was an inhibition of the hyperactivation caused by agents that induce an increase in cAMP concentrations. In conclusion, results from the present study indicate that P4 and E2 promote mechanisms regulating the acrosome reaction in ram spermatozoa, however, these effects on mechanisms are different for the two hormones, and for E2, require further clarification